Last month, BEL software SOURCERER achieved FDA 510(k) clearance. "FDA clearance of SOURCERER has been a major goal of our team and for the BEL Quality Management System,” said Dr. Don Tucker, CEO and Founder of BEL Company, and of Neurosom. BEL Company was founded in 2017 after a successful sale of a previous company, in order to expand the research and development of neuroscience technology. BEL has continued to develop groundbreaking software and hardware innovations for EEG and the study of the human brain.

Last month, Neurosom was thrilled to be featured on The Unicorn Hunt Podcast. CEO and founder Don Tucker explains the critical mission of improving health through Neurosom Sleep Therapy. Listen as Dr. Tucker dives into the science behind the mechanisms at work during sleep, how Sleep Therapy is able to improve restorative deep sleep, and how AI is being used to accurately classify sleep stages during Sleep Therapy.

Neurosom partner company, BEL receives FDA 510(k) clearance for SOURCERER source estimation software. “SOURCERER is a next generation software that combines an elegant and easy user interface with a faster analysis, precise results, and a managed workflow.

Neurosom’s Sleep WISP Therapy is applied by the user, at home, through a headband worn during sleep. The headband system uses EEG and machine learning to accurately track the user’s sleep cycles. The system applies painless electrical stimulation to facilitate sleep onset as well as extend and enhance deep sleep.

BEL recognizes the SFN conference 2024 and the commitment to excellence in the neuroscience community. Of special interest is the lecture by Dr. Takeshi Iwatsubo on Disease-Modifying Therapies for Alzheimer's Disease. The Sleep WISP device for home sleep improvement is currently in a clinical trial to study Mild Cognitive Impairment funded by the National Institute of Aging.